Clinical Trial Update: A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a dose-escalation study of IG3018 in adults with hyperuricemia, with or without chronic kidney disease, across Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperuricemia
• Hypouricemia

Drugs mentioned

• IG3018

Snippet

Sponsor: Intelligem Therapeutics Australia Pty Ltd. | Conditions: Hyperuricemia, Hypouricemia, Renal | Phase 1, Phase 2 | Status: RECRUITING